Myelodysplastic syndrome.
Nakao
Shinji
S
Cellular Transplantation Biology, Division of Cancer Medicine, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa City, Ishikawa 920-8641, Japan. snakao@med3.m.kanazawa-u.ac.jp
Deeg
H Joachim
HJ
Ishikawa
Takayuki
T
Marsh
Judith
J
List
Alan
A
Tomonaga
Masao
M
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D011878:Radiotherapy / Q000379:methods; D013234:Stem Cells / Q000473:pathology
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine